Experimental animal studies have demonstrated that salidroside exhibits neuroprotective effects by inhibiting neuronal ferroptosis in Amyloid beta peptide (Aβ)1-42-induced AD mice and Glu-injured HT22 cells. Here, APP is linked to Alzheimer disease.